About Us

---

Co-Founder & CEO, Chair

Jim is a Co-Founder, CEO, and Chair of Durendal AI Inc. He is a technology executive and AI strategist with a proven record of building and scaling ventures at the intersection of artificial intelligence, healthcare, and enterprise systems. Over the course of his career, Jim has played a founding role in four startups—spanning advanced technology and healthcare services—all of which have achieved successful outcomes, including acquisition or continued independent growth.
 

With more than 25 years of leadership experience, Jim has held senior roles at Oracle, IBM, Roche, and Genentech, where he led large-scale initiatives in AI innovation, health informatics, and cloud architecture. He has directed international software development teams spanning Europe, Israel, India, China, and Australia, and worked closely with globally distributed business development and solution delivery teams across the Americas, EMEA, and Asia-Pacific regions. At both IBM and Oracle, Jim was instrumental in enterprise transformations for institutions such as Mount Sinai, Mayo Clinic, and MD Anderson, driving integration of AI, analytics, and data platforms into high-stakes clinical environments.
 

Earlier in his career, Jim served as a Staff Scientist at Lawrence Berkeley National Laboratory, contributing to a NASA-funded program studying the biological effects of high-energy charged particle radiation. He also advanced multi-modal medical image reconstruction using Bayesian and maximum likelihood approaches.
 

Jim earned his PhD in Biophysics from the University of California, Berkeley. 

Co-Founder, CSO, CPO & Board of Directors

 Josh is a scientist, entrepreneur, and innovation strategist with more than 15 years of experience spanning biotechnology, regenerative medicine, advanced manufacturing, healthcare, and emerging technologies. As Co-Founder, Chief Scientific Officer (CSO), Chief Partnerships Officer (CPO), and member of the Board of Directors at Durendal AI, Josh helps guide the company's scientific strategy and leads the development and management of strategic alliances, commercial partnerships, and collaborative relationships across industry, academia, and government.

Throughout his career, Josh has focused on translating scientific advances and emerging technologies into collaborative programs and commercial opportunities. He has helped secure, lead, or support more than $30 million in federal, state, philanthropic, and industry-funded initiatives, and helped expand an advanced biotechnology test bed to more than 20 industry partners. His experience encompasses regenerative medicine, advanced biomanufacturing, AI-enabled biotechnology, commercialization, and the development of public-private innovation ecosystems.

Josh earned his PhD in Neuroscience from Yale University and conducted research at Yale, the National Institutes of Health, and Pfizer. His scientific and strategic contributions include more than 45 peer-reviewed publications, book chapters, and strategic roadmaps. He is also Founder and Principal of Joshua Hunsberger LLC, an independent consulting and advisory firm focused on innovation strategy, commercialization, and partnerships.

At Durendal AI, Josh combines scientific expertise, entrepreneurial experience, and a demonstrated ability to build collaborative relationships. He helps connect the company's AI capabilities with complementary organizations, technologies, and commercial opportunities to advance innovation and deliver practical, real-world solutions.

CTO, CAIO & Board of Directors, AI Strategy 

  Hans serves as Chief Technology Officer (CTO), Chief Artificial Intelligence Officer (CAIO), and a member of Durendal AI's Board of Directors. A technology executive and AI strategist with more than a decade of experience in artificial intelligence, healthcare, and life sciences, he guides the company's technology vision and enterprise AI strategy.

At Oracle, Hans directed more than 80 AI/ML initiatives and advised healthcare organizations and U.S. federal agencies, including the CDC, NIH, and Veterans Health Administration. He led multidisciplinary teams from strategic discovery through solution delivery. His work on an oncology AI recommendation system contributed to a $15 million enterprise contract renewal.

At Durendal AI, Hans leads advanced AI architecture, data strategy, and intelligent systems development for enterprise and scientific applications. As Co-Investigator and AI technical lead for the Cell and Gene Therapy Digital Infrastructure Consortium, he advances AI-enabled traceability, anomaly detection, and data governance across biomedical workflows. He also champions responsible AI governance in regulated environments.

Previously, Hans served as a Senior Research Software Engineer at the National Center for Supercomputing Applications, University of Illinois, where he contributed to AI evaluation frameworks and institutional innovation. His experience bridges scientific research, executive technology strategy, and practical deployment of emerging AI capabilities.

Hans earned his PhD in Informatics from the University of Illinois Urbana-Champaign, focusing on AI for biological systems. His work includes peer-reviewed scientific publications and invited presentations at national and international AI and healthcare conferences.

CMIO & Board of Directors, Health Analytics

  Patricio brings a global perspective and a multidisciplinary approach to Durendal AI, where he joins the Board of Directors and serves as Chief Medical Information Officer (CMIO). In addition to his leadership responsibilities, Dr. Muñiz advises the organization on healthcare outcomes, quality of care, operational efficiency, and cost optimization strategies.
 

A physician by training and a Fulbright Scholar, Dr. Muñiz holds advanced degrees in Public Health and Business Administration from Johns Hopkins University. He is recognized for his pioneering work in developing scalable health data platforms and analytic frameworks that have transformed healthcare delivery across multiple countries.
 

As Executive Director of Med-iQ in Santiago, Chile since 2009, Dr. Muñiz has led the design and implementation of modular health data repositories, including the innovative 'Mórula' platform. His leadership has supported the deployment of morbidity-adjusted financing models and integrated analytics platforms now used by over 20 private hospitals in Chile. He has also worked closely with Johns Hopkins University in supporting international coding systems and adapting the ACG risk adjustment model to the Latin American context.
 

Previously, he served as International Product Development Director for ACG International at the Johns Hopkins School of Public Health (2008–2012), where he oversaw global adaptation of risk models and supported clients across Latin America, Europe, and Africa. He has also provided consulting expertise in healthcare quality improvement, pricing models, and administrative system optimization.
 

Dr. Muñiz’s entrepreneurial track record includes founding multiple successful startups at the intersection of health informatics, public health policy, and clinical operations. He is fluent in Spanish and English, with working proficiency in Portuguese.
 

With over two decades of experience across continents, Dr. Muñiz is uniquely positioned to guide Durendal AI’s strategic efforts to integrate advanced technologies with real-world healthcare systems, ensuring value-based, data-driven care delivery on a global scale.

Advisory Board, DS Solutions

  Sanjay serves on Durendal AI's Advisory Board. With over two decades of experience in artificial intelligence, clinical analytics, and enterprise data strategy, Sanjay has led multidisciplinary initiatives across life sciences, healthcare, financial services, and consumer markets.

He has served in senior technical and leadership roles at Bank of America, IQVIA, ZS Associates, EY, IBM, and Deloitte, where he delivered advanced machine learning, real-world evidence, master data management, and big data solutions. His work has helped global organizations drive better outcomes in clinical development, healthcare operations, and commercial analytics. At Smart Analytics, where he is also Chief Technology Officer, Sanjay has developed AI frameworks to reduce healthcare costs, improve predictive accuracy, and uncover behavioral insights from social and call center data.

Sanjay holds a PhD in Artificial Intelligence from Drexel University, where his research focused on learning from human experts. His published work spans predictive modeling, image understanding, and clinical informatics, including a recent article in BMJ Health & Care Informatics. He also holds patents pending for devices and algorithms supporting early disease detection and has contributed to the development of telemedicine platforms that promote collaboration across providers.

At Durendal AI, Sanjay leads data science strategy and innovation, bringing deep technical expertise and a passion for applying AI to complex biomedical and public health challenges.

Advisory Board, Emerging Technology

 Josh brings a distinguished track record of academic, professional, and community engagement to his role on Durendal AI's Advisory Board, where he serves as Advisor for Innovation and Emerging Technology. Deeply committed to advancing the intersection of healthcare, technology, and education, Mr. Tan has served on numerous advisory boards spanning academic institutions, workforce development initiatives, and regional innovation hubs.
 

He currently serves on the advisory boards of Winston-Salem State University (WSSU), Forsyth Technical Community College, and Camel City Support Initiative (CCSI), where he contributes strategic insight on emerging technologies, workforce alignment, and experiential learning. His prior board service includes roles with the Center for Design Innovation (CDI), the Technology Council of the Greater Winston-Salem Chamber of Commerce, and the UNC Asheville Alumni Association.
 

In his professional capacity, Mr. Tan is Systems Manager for the Department of Radiology and the Translational Imaging Program at Atrium Health Wake Forest Baptist. A seasoned imaging informatics specialist, computer programmer, and hardware expert, he supports multidisciplinary teams across clinical and research settings. His technical expertise includes 2D/3D/4D image reconstruction, segmentation and visualization, medical image analysis, 3D printing, and the use of extended reality (VR/AR/XR) in medical applications.
 

Mr. Tan has over 15 years of experience creating patient-specific 3D anatomical models derived from CT and MRI data for use in both clinical care and medical education. His work also encompasses DICOM validation, artificial intelligence in radiology, and the management of large-scale research imaging archives. He routinely collaborates in the evaluation and deployment of emerging alpha and beta-stage software and hardware technologies.
 

Josh Tan’s unique combination of technical depth, community leadership, and forward-thinking innovation makes him a valuable asset to Durendal AI’s mission to accelerate healthcare transformation through AI and advanced technology.